Alembic Pharmaceuticals announced the superannuation of Mr. Ashok Pandya from his position as Resident Director, effective January 31, 2026. Mr. Pandya’s departure marks the end of his tenure. This change in senior management personnel is effective after the closure of business hours on January 31, 2026. Further details regarding this transition are disclosed in the company’s official statement.
Leadership Transition
Alembic Pharmaceuticals confirms that Mr. Ashok Pandya has superannuated from his role as Resident Director. This change came into effect on January 31, 2026.
Details of Departure
The superannuation of Mr. Ashok Pandya occurred on January 31, 2026, after the close of business hours. The company has not provided any additional information regarding a replacement or interim appointment as of the date of this announcement. This marks a shift in the company’s leadership structure.
Source: BSE
